MedPath

Chewing Gum vs. Ondansetron as Rescue Treatment for PONV in Female Patients

Not Applicable
Active, not recruiting
Conditions
Postoperative Nausea and Vomiting (PONV)
Interventions
Other: chewing gum
Combination Product: Ondansetron + Chewing gum
Registration Number
NCT07201883
Lead Sponsor
Makassed General Hospital
Brief Summary

The proposed randomized clinical trial aims to test and compare the efficacy of chewing gum vs. Intravenous antiemetic ondansetron as rescue treatment for post-operative nausea and vomiting (PONV) among Lebanese female patients undergoing laparoscopic surgery in the post-operative anesthesia care unit (PACU).

Detailed Description

Post-operative nausea and vomiting remains a significant complication following general anesthesia, particularly when volatile anesthetics are used. Previous studies, including a multicenter randomized trial conducted in Australia, have explored alternative treatment modalities for PONV. Chewing gum, a non-pharmacological intervention, has shown promise as a potential alternative or adjunct to conventional antiemetics like ondansetron. This study focuses on the Lebanese female population, aged 18 and above, who have undergone laparoscopic surgery under volatile anesthetic-based general anesthesia. This demographic is chosen based on established risk factors for PONV and may offer unique insights into efficacy within this subgroup.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
90
Inclusion Criteria
  • Females
  • Aged 18 and above,
  • Weight 40kg and above,
  • Who have undergone laparoscopic
  • Surgery under volatile anesthetic-based general anesthesia.
Exclusion Criteria
  • Have history of motion sickness,
  • Maintained anesthesia during surgery using Propofol-pump
  • Were given antiemetics within 8 hours pre-surgery
  • Allergy to ondansetron
  • Planned mechanical ventilation post-operation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
OndansetronOndansetron (Zofran)-
Chewing Gumchewing gum-
Ondansetron + Chewing GumOndansetron + Chewing gum-
Primary Outcome Measures
NameTimeMethod
Complete cessation of PONV with no recurrence and no rescue medication2 hours
Secondary Outcome Measures
NameTimeMethod
Patient satisfactionpost-operative period ( up to 3 hours)
Quantity of rescue treatment modalities usedimmediately after PONV start until complete resolution of symptoms

Trial Locations

Locations (1)

Makassed General Hospital

🇱🇧

Beirut, Lebanon

Makassed General Hospital
🇱🇧Beirut, Lebanon

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.